Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.7076
-0.0028 (-0.39%)
At close: Nov 7, 2025, 4:00 PM EST
0.7199
+0.0123 (1.74%)
After-hours: Nov 7, 2025, 5:22 PM EST
Cytosorbents Revenue
Cytosorbents had revenue of $9.62M in the quarter ending June 30, 2025, with 8.76% growth. This brings the company's revenue in the last twelve months to $36.11M, up 20.18% year-over-year. In the year 2024, Cytosorbents had annual revenue of $35.59M with 14.51% growth.
Revenue (ttm)
$36.11M
Revenue Growth
+20.18%
P/S Ratio
1.14
Revenue / Employee
$242,332
Employees
149
Market Cap
44.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35.59M | 4.51M | 14.51% |
| Dec 31, 2023 | 31.08M | -3.60M | -10.39% |
| Dec 31, 2022 | 34.69M | -8.48M | -19.64% |
| Dec 31, 2021 | 43.17M | 2.16M | 5.27% |
| Dec 31, 2020 | 41.00M | 16.06M | 64.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
CTSO News
- 9 days ago - CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights - PRNewsWire
- 11 days ago - In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer - PRNewsWire
- 5 weeks ago - CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen - PRNewsWire
- 7 weeks ago - CytoSorbents Provides DrugSorb-ATR Regulatory Update - PRNewsWire
- 2 months ago - CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day - PRNewsWire
- 2 months ago - CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference - PRNewsWire
- 2 months ago - CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR - PRNewsWire
- 3 months ago - Cytosorbents Corporation (CTSO) Q2 2025 Earnings Call Transcript - Seeking Alpha